To read the original story from Boston University Center for Emerging Infectious Diseases Policy & Research please click here.
We are excited to announce a partnership between CEID and Connected DMV. We will be cooperating with Connected DMV in their Pandemic Prevention and Biodefense Initiative and serve as a key partner in the Global Pandemic Prevention and Biodefense Center and AHEAD100 initiative.
Connected DMV’s Global Pandemic Prevention & Biodefense Center aims to harness all of the rich talent and critical health research, biotech, defense, and government assets that the world has to offer to deliver a full-scale response. The flagship lead initiative of the Center is AHEAD100, an ambitious, medical countermeasures program aims to develop and stockpile monoclonal antibodies (mAbs) for the world’s top 100 pathogens across 25 pathogen families most likely to cause pandemics. The availability of this stockpile fills the critical time gap between outbreaks and activated vaccines during which a pandemic can be wholly avoided. Learn more about Connected DMV and the Global Pandemic Prevention & Biodefense Center at www.pandemicprevention.org.
Dr. Bhadelia will serve on the Steering Committee of the Pandemic Prevention and Biodefense Initiative in the DMV, and CEID faculty will provide expertise and strategic guidance for the new venture through this cooperation. We look forward to joining forces with Connected DMV in helping build global resilience against emerging infectious disease threats.